For the year ending 2025-12-31, IDYA has $1,109,324K in assets. $86,390K in debts. $112,825K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 112,825 | |||
| Short-term marketable securities | 526,563 | |||
| Prepaid expenses and other current assets | 21,366 | |||
| Contract assets | 5,973 | |||
| Total current assets | 666,727 | |||
| Restricted cash | 1,015 | |||
| Long-term marketable securities | 410,297 | |||
| Total property and equipment | 22,473 | |||
| Less accumulated depreciation and amortization | 14,256 | |||
| Property and equipment, net | 8,217 | |||
| Right-of-use assets | 23,068 | |||
| Total assets | 1,109,324 | |||
| Accounts payable | 17,584 | |||
| Accrued liabilities | 40,892 | |||
| Operating lease liabilities, current | 339 | |||
| Total current liabilities | 58,815 | |||
| Long-term operating lease liabilities | 27,575 | |||
| Total liabilities | 86,390 | |||
| Common stock, 0.0001 par value, 300,000,000 shares authorized as of december 31, 2025 and december 31, 2024 87,796,561 and 86,503,509 shares issued and outstanding as of december 31, 2025 and december 31, 2024 | 9 | |||
| Additional paid-in capital | 1,757,197 | |||
| Accumulated other comprehensive income | 2,267 | |||
| Accumulated deficit | -736,539 | |||
| Total stockholders equity | 1,022,934 | |||
| Total liabilities and stockholders equity | 1,109,324 | |||
IDEAYA Biosciences, Inc. (IDYA)
IDEAYA Biosciences, Inc. (IDYA)